Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Vir Biotechnology, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 207
- −5 vs. Q3 2023
- Shares held
- 88.2M
- +8.42K (0.0%) vs. Q3 2023
- Total value
- $887.2M
- +$61.0M (+7.4%) vs. Q3 2023
- New holders
- 29
- 69 more added
- Sold out
- 34
- 73 more reduced
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 237 | $1.49B |
| Q1 2026 | 252 | $1.25B |
| Q4 2025 | 218 | $696.5M |
| Q3 2025 | 213 | $610.8M |
| Q2 2025 | 213 | $558.5M |
| Q1 2025 | 234 | $604.5M |
| Q4 2024 | 208 | $652.0M |
| Q3 2024 | 197 | $656.3M |
| Q2 2024 | 215 | $783.1M |
| Q1 2024 | 210 | $901.0M |
| Q4 2023 | 207 | $887.2M |
| Q3 2023 | 215 | $827.4M |
| Q2 2023 | 227 | $2.23B |
| Q1 2023 | 234 | $2.06B |
| Q4 2022 | 225 | $2.18B |
| Q3 2022 | 221 | $1.68B |
| Q2 2022 | 214 | $2.20B |
| Q1 2022 | 204 | $2.09B |
| Q4 2021 | 210 | $3.25B |
| Q3 2021 | 175 | $3.24B |
| Q2 2021 | 166 | $3.64B |
| Q1 2021 | 157 | $3.87B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alliancebernstein L.P. | 2,781,049 | $28.0M | 0.01% | −116,685−4.0% | Reduced |
| Citadel Advisors LLC | 3,037,948 | $30.6M | 0.03% | +2,954,409+3,536.6% | Added |
| Baillie Gifford & Co | 3,965,549 | $39.9M | 0.03% | −6,022−0.2% | Reduced |
| State Street Corp | 6,912,082 | $69.5M | 0.00% | −261,346−3.6% | Reduced |
| Vanguard Group Inc | 12,297,139 | $123.7M | 0.00% | +1,096,473+9.8% | Added |
| SB Investment Advisers (UK) Ltd | 16,684,041 | $167.8M | 1.49% | 00.0% | Unchanged |
| BlackRock Inc. | 16,864,579 | $169.7M | 0.00% | +1,060,666+6.7% | Added |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −708,257−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −325,050−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −235,604−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −162,128−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −117,131−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −106,808−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −93,752−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −70,606−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −67,202−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −63,057−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −50,263−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −44,205−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −42,266−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −38,739−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −38,000−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −23,022−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −19,427−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −15,900−100.0% | Sold out |
| Vise Technologies, Inc. | 0 | $0 | 0.00% | −15,861−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −14,943−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −13,483−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −10,531−100.0% | Sold out |
| DCF Advisers, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −2,111−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,799−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −1,586−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −1,549−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −184−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Milestone Investment Advisors LLC | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Prestige Wealth Management Group LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −11,026−100.0% | Sold out |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| Quantamental Technologies LLC | – | – | – | – | Not filed |